Clinical Trial Categories
Colorectal Trials
Trial ID 20266
NCT04485013clinicaltrials.gov ID
USOR ID: 20266
Phase Ib
A Phase 1a/1b Dose Escalation/Expansion Study of TTX-080, an HLA-G Antagonist, as Monotherapy and in Combination with Pembrolizumab or Cetuximab in Patients with Advanced Solid Refractory/Resistant Malignancies
Trial ID 20318
NCT04793958clinicaltrials.gov ID
USOR ID: 20318
Phase III
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy
Trial ID 20341
NCT04264702clinicaltrials.gov ID
USOR ID: 20341
BESPOKE: Study of ctDNA Guided Therapy in Colorectal Cancer
Trial ID 20422
USOR ID: 20422
KRAS DetECT: KRAS mutation Detection to Evaluate Eligibility for Clinical Trials
